Mercados

Empiricus encaminha questionamentos sobre Marfrig à SEC

Analistas continuam a apontar inconsistências contábeis em balanço; empresa nega

Marfrig empresa (Divulgação)

Marfrig empresa (Divulgação)

DR

Da Redação

Publicado em 2 de dezembro de 2011 às 14h38.

São Paulo – A casa de análise Empiricus continua a apontar inconsistências contábeis no balanço do frigorífico Marfrig e encaminhou nesta sexta-feira os questionamentos ao órgão regulador do mercado de capitais americano (SEC – Securities and Exchange Commission).

Os analistas levantaram dúvidas sobre o rigor das demonstrações financeiras em um relatório publicado no dia 28 de novembro. Segundo eles, a empresa precisaria republicar os balanços dos anos anteriores, o que poderia levar ao não cumprimento dos covenants dos títulos da dívida.

O frigorífico disse em uma nota que cumpriu plenamente todas as normas do IRFS e que os questionamentos e considerações da Empiricus carecem de fundamento. “A Empresa entende que cumpriu plenamente todas as normas do IRFS e que os questionamentos e considerações do blog Empiricus carecem de fundamento”.

Veja o questionamento:

“Empiricus is a Brazilian Independent Research House. I am Marcos Elias, founder of the company. Marfrig is a meat and beef processing company, having issued ADR level I. Our research team has promoted a tour de force, an in-depth analysis of Marfrig's current and past balance sheet, nailing down several inconsistencies. These were put down in a form of an Open Letter. Company refrained from answering the letter, besides providing to public a small declaration - argumentum ad verecudiam - alleging to be a well reputed listed company audited by KPMG. KPMG has also provided a public note declaring it will not address the supposed accounting inconsistencies due to confidentiality agreements and loyalty issues with the client. In the next few days we will keep the pace, making addenda to our open letter, as our internal auditing squad piles up more inconsistencies.

We hope to get answers from the company in a written form, openly, in order to avoid distortions and misunderstandings. As of today, Marfrig is collecting tens of public questionings over its accounting practices that can be accessed at CVM's Brazilian SEC. Discrepancies amounts to over R$ 1 billion, if we only take 2010 fiscal year. Our understanding is that the company deliberately understated its debt to EBITDA, EBITDA to interest and debt to book value ratios to mask covenants blew up, and it should republish current and past balance sheets.

Additionally, anedoctal evidence shows the company opportunistically used the IFRS accounting transition to hide liabilities. Given Empiricus' findings over accounting inconsistencies detected over several financial statements of Marfrig (MFRG3) - which are being made public to clients through open letters and annexes (no answers so far from the company or their auditor, KPMG) - and considering the vast amount of different investigations held by Brazilian's SEC CVM over the theme on Marfrig (enter http://www.cvm.gv.br, then go to "consulta a processos", type "Marfrig" in the field "Requerente/Interessado" and more than 20 internal proceedings will pop up, some under the title "noncompliance detected"), we are confident over the scenario of our SEC demanding 2009-2011 financial statements to be restated. Restatement of balance sheets will lead to debt covenants blow up (for instance net debt to ebitda should be no greater than 4,75%, for a bond of R$ 2,5B issued in 07/15/2010), triggering early redemption of almost R$ 6B in bonds.

If it happens, Marfrig won't be able to meet its obligations (since it burns cash operationally and holds less than R$ 2,5B in total cash for a financial debt piling up to R$ 15B), and it will default. So, in my opinion, Marfrig's solvency (and liquidity for the whole value chain) is being held by a threat, that will stand if authorities does not demand FS restatements”.

Acompanhe tudo sobre:Alimentos processadosB3bolsas-de-valoresCarnes e derivadosEmpresasEmpresas brasileirasMarfrig

Mais de Mercados

CVC sobe 7% na bolsa com poison pill e alta das ações domésticas

Em meio a pressão por boicotes, ação do Carrefour sobe 3,31%

O saldo final – e os vencedores – da temporada de balanços do 3º tri, segundo três análises

Warren Buffett doa US$ 1,1 bilhão em ações da Berkshire Hathaway: "Nunca quis criar uma dinastia"